MSF Access
@msfaccess.org
On #WorldAMRAwarenessWeek, we’re calling for concrete action to ensure access to existing diagnostic tools, microbiology capacities, legacy & new lifesaving antibiotics, and care for all...
+ an increase in R&D for low-resource & humanitarian settings, where it's most needed.
+ an increase in R&D for low-resource & humanitarian settings, where it's most needed.
November 24, 2025 at 10:18 AM
On #WorldAMRAwarenessWeek, we’re calling for concrete action to ensure access to existing diagnostic tools, microbiology capacities, legacy & new lifesaving antibiotics, and care for all...
+ an increase in R&D for low-resource & humanitarian settings, where it's most needed.
+ an increase in R&D for low-resource & humanitarian settings, where it's most needed.
🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide.
For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe.
#WorldAMRAwarenessWeek
For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe.
#WorldAMRAwarenessWeek
November 20, 2025 at 12:20 PM
🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide.
For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe.
#WorldAMRAwarenessWeek
For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe.
#WorldAMRAwarenessWeek
AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products?
If you're curious, read our latest newsletter, and sign up for more access content!
msfaccess.org/newsletter/a...
If you're curious, read our latest newsletter, and sign up for more access content!
msfaccess.org/newsletter/a...
AMR, FTAs, TB: spelling out the access issues
Acronyms and global health often seem to go together. On the one hand, abbreviations like acronyms can be useful when you need to have a quick and easy way to talk about a complicated topic, especiall...
msfaccess.org
November 19, 2025 at 5:21 PM
AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products?
If you're curious, read our latest newsletter, and sign up for more access content!
msfaccess.org/newsletter/a...
If you're curious, read our latest newsletter, and sign up for more access content!
msfaccess.org/newsletter/a...
This World AMR Awareness Week, join a discussion on antimicrobial resistance in conflict-affected settings, where AMR's impact is severe due to limited access to infection prevention, diagnostics, and antimicrobials.
📅 Thur 20 Nov
🕐 13:30 – 15:00 CET
fao.zoom.us/webinar/regi...
📅 Thur 20 Nov
🕐 13:30 – 15:00 CET
fao.zoom.us/webinar/regi...
Video Conferencing, Web Conferencing, Webinars, Screen Sharing
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...
fao.zoom.us
November 19, 2025 at 9:45 AM
This World AMR Awareness Week, join a discussion on antimicrobial resistance in conflict-affected settings, where AMR's impact is severe due to limited access to infection prevention, diagnostics, and antimicrobials.
📅 Thur 20 Nov
🕐 13:30 – 15:00 CET
fao.zoom.us/webinar/regi...
📅 Thur 20 Nov
🕐 13:30 – 15:00 CET
fao.zoom.us/webinar/regi...
Today at @theunion.org we unveiled data from our operational research:
⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉
msfaccess.org/msf-findings...
⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉
msfaccess.org/msf-findings...
MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB
Governments must act now to ensure no child is left behind in the fight against this deadly disease
msfaccess.org
November 18, 2025 at 5:53 PM
Today at @theunion.org we unveiled data from our operational research:
⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉
msfaccess.org/msf-findings...
⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉
msfaccess.org/msf-findings...
Today is World Diabetes Day.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
November 14, 2025 at 11:14 AM
Today is World Diabetes Day.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
November 13, 2025 at 6:16 PM
Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
It's starting soon!
www.youtube.com/watch?v=XBqQ...
www.youtube.com/watch?v=XBqQ...
November 13, 2025 at 1:13 PM
It's starting soon!
www.youtube.com/watch?v=XBqQ...
www.youtube.com/watch?v=XBqQ...
Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
November 12, 2025 at 3:22 PM
Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
Half of children and young adolescents with tuberculosis are not diagnosed and therefore do not receive lifesaving treatment… but why?
Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion.
youtu.be/6k6YCqPUi_Y
Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion.
youtu.be/6k6YCqPUi_Y
November 7, 2025 at 5:13 PM
Half of children and young adolescents with tuberculosis are not diagnosed and therefore do not receive lifesaving treatment… but why?
Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion.
youtu.be/6k6YCqPUi_Y
Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion.
youtu.be/6k6YCqPUi_Y
Every child withTB deserves a healthy childhood. Yet in 2023, 1.25M fell ill with TB and nearly half were never diagnosed, thus never treated.
Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.
Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.
October 27, 2025 at 3:24 PM
Every child withTB deserves a healthy childhood. Yet in 2023, 1.25M fell ill with TB and nearly half were never diagnosed, thus never treated.
Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.
Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.
🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year.
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
October 24, 2025 at 4:03 PM
🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year.
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
➡️ @saludporderecho.bsky.social reports that in Spain the public price of WHO recommended six-month treatment BPaLM regimen is priced at €58,000. In contrast, LMICs can access the same regimen for less than €250.
saludporderecho.org/en/monopolie...
saludporderecho.org/en/monopolie...
October 23, 2025 at 2:21 PM
➡️ @saludporderecho.bsky.social reports that in Spain the public price of WHO recommended six-month treatment BPaLM regimen is priced at €58,000. In contrast, LMICs can access the same regimen for less than €250.
saludporderecho.org/en/monopolie...
saludporderecho.org/en/monopolie...
💊Patents, trade policy, and why people's access to the medicines they need is at stake.
MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.
MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.
🚨 Medicine prices in India are under threat.
New Free Trade Agreements with developed countries could mean higher medicine prices and block affordable generics.
🧵 Here’s how 👇
#AccessDenied episode▶️https://youtu.be/tXLE_jJF8xk
New Free Trade Agreements with developed countries could mean higher medicine prices and block affordable generics.
🧵 Here’s how 👇
#AccessDenied episode▶️https://youtu.be/tXLE_jJF8xk
October 22, 2025 at 1:46 PM
💊Patents, trade policy, and why people's access to the medicines they need is at stake.
MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.
MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.
MSF first witnessed the systemic gaps in access to WHO-recommended #tuberculosis treatments in 2022 when we launched a response in Poland to assist Ukrainian refugees and other migrants in accessing tuberculosis treatment.
A TB survivor shared her experience 🧵
A TB survivor shared her experience 🧵
October 15, 2025 at 1:20 PM
MSF first witnessed the systemic gaps in access to WHO-recommended #tuberculosis treatments in 2022 when we launched a response in Poland to assist Ukrainian refugees and other migrants in accessing tuberculosis treatment.
A TB survivor shared her experience 🧵
A TB survivor shared her experience 🧵
At a panel discussion yesterday in Brussels, we urged policymakers, parliamentarians, regulatory agencies, and procurement bodies in the EU and the EEA to take urgent steps to bridge the gap in accessing tuberculosis treatment in the region.
msfaccess.org/msf-urges-eu...
msfaccess.org/msf-urges-eu...
October 15, 2025 at 1:15 PM
At a panel discussion yesterday in Brussels, we urged policymakers, parliamentarians, regulatory agencies, and procurement bodies in the EU and the EEA to take urgent steps to bridge the gap in accessing tuberculosis treatment in the region.
msfaccess.org/msf-urges-eu...
msfaccess.org/msf-urges-eu...
⏰ Tomorrow! Don’t miss our panel on improving access to TB medicines in EU/EEA. People with TB still face barriers to effective treatment & prevention, let's discuss solutions.
Register Now👉 us06web.zoom.us/webinar/regi...
Register Now👉 us06web.zoom.us/webinar/regi...
October 13, 2025 at 1:29 PM
⏰ Tomorrow! Don’t miss our panel on improving access to TB medicines in EU/EEA. People with TB still face barriers to effective treatment & prevention, let's discuss solutions.
Register Now👉 us06web.zoom.us/webinar/regi...
Register Now👉 us06web.zoom.us/webinar/regi...
People with TB in EU and EEA still face limited access to effective treatment and prevention medicines. How can we fix that? On 14 Oct, join our panel discussion on how to improve the availability and affordability of TB medicines in the region.
Register us06web.zoom.us/webinar/regi...
Register us06web.zoom.us/webinar/regi...
October 8, 2025 at 1:59 PM
People with TB in EU and EEA still face limited access to effective treatment and prevention medicines. How can we fix that? On 14 Oct, join our panel discussion on how to improve the availability and affordability of TB medicines in the region.
Register us06web.zoom.us/webinar/regi...
Register us06web.zoom.us/webinar/regi...
Ahead of the WHO Eastern Mediterranean Regional Committee, MSF shared challenges in addressing antimicrobial resistance in fragile & conflict settings, where it's critical to measure access gaps & improve availability of diagnostics & antibiotics.
www.emro.who.int/media/news/i...
www.emro.who.int/media/news/i...
WHO EMRO - Integrating antimicrobial stewardship and infection control in primary health care facilities
www.emro.who.int
September 30, 2025 at 2:21 PM
Ahead of the WHO Eastern Mediterranean Regional Committee, MSF shared challenges in addressing antimicrobial resistance in fragile & conflict settings, where it's critical to measure access gaps & improve availability of diagnostics & antibiotics.
www.emro.who.int/media/news/i...
www.emro.who.int/media/news/i...
While most countries agreed to the UN HLM Declaration on prevention & control of NCDs & mental health, it was not adopted.
We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.
We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.
September 26, 2025 at 5:05 PM
While most countries agreed to the UN HLM Declaration on prevention & control of NCDs & mental health, it was not adopted.
We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.
We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.
We welcome the agreement to provide ground-breaking HIV prevention drug at $40 in 2027, but global plans need to prioritise key populations and include the low- and middle-income countries to ensure sustainable access for all who need it.
msfaccess.org/msf-supports...
msfaccess.org/msf-supports...
MSF Supports $40 PrEP Access by 2027, Demands Broader Reach and more Ambition to End HIV Epidemic
MSF welcomes the new $40 Lenacapavir agreement for 2027, but urges inclusion of key populations and LMICs currently left out of the license.
msfaccess.org
September 26, 2025 at 2:19 PM
We welcome the agreement to provide ground-breaking HIV prevention drug at $40 in 2027, but global plans need to prioritise key populations and include the low- and middle-income countries to ensure sustainable access for all who need it.
msfaccess.org/msf-supports...
msfaccess.org/msf-supports...
⏰ Tomorrow, governments will gather at the United Nations High Level Meeting (UN HLM) in New York to agree to a political declaration that will guide them on how to prevent and control noncommunicable diseases (NCDs) – including diabetes – and mental health until 2030.
🧵
🧵
September 24, 2025 at 8:58 AM
⏰ Tomorrow, governments will gather at the United Nations High Level Meeting (UN HLM) in New York to agree to a political declaration that will guide them on how to prevent and control noncommunicable diseases (NCDs) – including diabetes – and mental health until 2030.
🧵
🧵
What happens when people face challenges accessing the diabetes care they need?
Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.
msfaccess.org/what-it-mean...
Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.
msfaccess.org/what-it-mean...
What it means to lose access to diabetes care: stories from people living with diabetes around the world
Managing diabetes is complicated. Even with access to the best tools and technology, it requires constant blood sugar level monitoring and daily treatment in the form of medication or insulin.
msfaccess.org
September 23, 2025 at 9:27 AM
What happens when people face challenges accessing the diabetes care they need?
Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.
msfaccess.org/what-it-mean...
Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.
msfaccess.org/what-it-mean...
Scientists who discovered #insulin over 100 years ago envisioned a world where everyone could access diabetes treatment.
And yet, diabetes treatment is too often unavailable or unaffordable.
Learn more ⬇️
youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be
And yet, diabetes treatment is too often unavailable or unaffordable.
Learn more ⬇️
youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be
Diabetes (r)evolution(s)
YouTube video by MSF Access Campaign
youtube.com
September 22, 2025 at 10:42 AM
Scientists who discovered #insulin over 100 years ago envisioned a world where everyone could access diabetes treatment.
And yet, diabetes treatment is too often unavailable or unaffordable.
Learn more ⬇️
youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be
And yet, diabetes treatment is too often unavailable or unaffordable.
Learn more ⬇️
youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be
Fleeing home while managing #diabetes can mean losing reliable access to insulin which, in turn, risks severe health consequences, even death.
Ghassan undertook a long, difficult journey with a limited supply of insulin.
How did he manage his treatment?
🧵
Ghassan undertook a long, difficult journey with a limited supply of insulin.
How did he manage his treatment?
🧵
September 22, 2025 at 8:56 AM
Fleeing home while managing #diabetes can mean losing reliable access to insulin which, in turn, risks severe health consequences, even death.
Ghassan undertook a long, difficult journey with a limited supply of insulin.
How did he manage his treatment?
🧵
Ghassan undertook a long, difficult journey with a limited supply of insulin.
How did he manage his treatment?
🧵